Embla Medical hf.
OSSUY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.8B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.80 Billion |
|---|---|
| Enterprise Value | $2.25 Billion |
| Earnings per Share | $0.2 |
| Beta | 0.46 |
| Outstanding Shares | 425,252,638 |
Return
| Return on Equity | 10.24% |
|---|---|
| Return on Assets | 5.49% |
| Return on Invested Capital | 10.45% |
Valuation & Multiples
| P/E Ratio | 17.98 |
|---|---|
| PEG | 798.48 |
| Price to Sales | 2.12 |
| Price to Book Ratio | 2.12 |
| Enterprise Value to Revenue | 2.26 |
| Enterprise Value to EBIT | 16.05 |
| Enterprise Value to Net Income | 23 |
| Total Debt to Enterprise | 0.25 |
| Debt to Equity | 0.6 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Embla Medical hf.
4,500 employees
CEO: Sveinn Sölvason
Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bra...